Intraoperative Radiation Therapy (IORT) in DCIS
NCT03216421 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 265
Last updated 2025-08-19
Summary
The goal of this study is to examine the role of Intraoperative Radiotherapy (IORT) in Ductal Carcinoma In-Situ (DCIS) and to improve the understanding of the clinical, radiographic, and patient-related impact of adopting IORT.
Conditions
- Breast Cancer
- Ductal Carcinoma in Situ
Interventions
- OTHER
-
Quality of Life Questionnaires
Quality of Life questionnaires will be completed by each subject.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Eileen Connolly, MD · Assistant Professor of Radiation Oncology
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-09-12
- Primary Completion
- 2027-08-01
- Completion
- 2029-12-31
Countries
- United States
Study Locations
More Related Trials
-
High Dose Rate Intracavitary Brachytherapy as the Sole Method of Radiation Therapy for Breast Carcinoma
NCT00165581 ·Status: TERMINATED ·Phase: NA
-
Liposomal Doxorubicin Before Mastectomy in Treating Women With Invasive Breast Cancer
NCT00290732 ·Status: COMPLETED ·Phase: PHASE1
-
Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
NCT00003857 ·Status: COMPLETED ·Phase: PHASE3
-
Letrozole in Treating Postmenopausal Women With Ductal Carcinoma in Situ
NCT01439711 ·Status: COMPLETED ·Phase: PHASE2
-
Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer
NCT00136539 ·Status: COMPLETED ·Phase: PHASE2
-
Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole
NCT00077168 ·Status: UNKNOWN ·Phase: PHASE2
-
Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma
NCT03909282 ·Status: RECRUITING ·Phase: NA
-
Observational of Adjuvant Treatment of Breast Cancer With Liposomal Doxorubicin Regimen
NCT05731258 ·Status: RECRUITING
-
Effect of Neoadjuvant Chemoradiation on Pathologic Complete Response Rates in Locally Advanced Breast Cancer Patients
NCT06631066 ·Status: COMPLETED ·Phase: NA
-
Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling
NCT03412643 ·Status: UNKNOWN ·Phase: PHASE2
-
Testing the Addition of an Anti-cancer Drug, Berzosertib, to the Usual Treatment (Radiation Therapy) for Chemotherapy-Resistant Triple-Negative and Estrogen and/or Progesterone Receptor Positive, HER2 Negative Breast Cancer
NCT04052555 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Neo-adjuvant Chemotherapy With Letrozole in Patients With Estrogen Receptor Positive/HER-2 Negative Breast Cancer
NCT03497702 ·Status: UNKNOWN ·Phase: PHASE2
-
High Dose Chemotherapy and Autologous Transplant for Breast Cancer
NCT00186641 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Stereotactic Radiotherapy for Breast Cancer
NCT03043794 ·Status: TERMINATED ·Phase: PHASE2
-
Metastases Directed Therapy for Oligometastatic Breast Cancer
NCT06144346 ·Status: RECRUITING ·Phase: NA
-
Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast
NCT00496808 ·Status: COMPLETED ·Phase: NA
-
Combination Weekly Taxotere™ With Iressa™ /Placebo in Metastatic Breast Cancer
NCT00319618 ·Status: COMPLETED ·Phase: PHASE2
-
CETRA: Neoadjuvant Caelyx and Trastuzumab in Her-2 Positive Breast Cancer
NCT00434031 ·Status: WITHDRAWN ·Phase: PHASE2
-
DESCARTES: De-ESCAlation of RadioTherapy in Patients With Pathologic Complete rESponse to Neoadjuvant Systemic Therapy
NCT05416164 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Breast Cancer Recurrence Rates Following Surgery in Women With Ductal Carcinoma In Situ
NCT00002934 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Neoadjuvant Chemotherapy of Breast Cancer
NCT00830544 ·Status: UNKNOWN ·Phase: PHASE2
-
Trastuzumab Rezetecan Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC
NCT07047755 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in Situ
NCT04666961 ·Status: RECRUITING ·Phase: PHASE2
-
A Multicenter Prospective Cohort Study of Adjuvant Therapy for BRCA1/2 Mutated Hormone Receptor-positive HER2-negative Early High-risk Breast Cancer
NCT06791161 ·Status: ENROLLING_BY_INVITATION
-
"Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Cancer"
NCT01641406 ·Status: UNKNOWN ·Phase: PHASE2